A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Arcturus Therapeutics Holdings Inc’s current trading price is -30.80% away from its 52-week high, while its distance from the 52-week low is 122.76%. The stock’s price range for this time frame has been between $8.04 and $25.88. The trading volume of the company’s shares in the Healthcare reached around 1.05 million for the day, which was evidently higher than the average daily volume of 0.53 million over the last three months.
Currently, the stock price of Arcturus Therapeutics Holdings Inc (ARCT) is $17.91. In the most recent trading session, the stock underwent a significant upswing, peaking at $140.0 after opening at $17.91. The stock touched a low of $42.0 before closing at $19.48.
The market performance of Arcturus Therapeutics Holdings Inc has been somewhat stable. Over the past year, the company’s stock achieved a high of $25.88 on 10/02/24, with the lowest value for the same timeframe being $8.04, recorded on 04/07/25.
How Financial Performance Impacts Market Capitalization
Arcturus Therapeutics Holdings Inc (ARCT) has experienced a quarterly rise of 53.73% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 486.34M and boasts a workforce of 176 employees.
Decoding Analysts’ Ratings for Arcturus Therapeutics Holdings Inc
As of right now, 8 analysts are rating Arcturus Therapeutics Holdings Inc as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 12.57, with a change in price of +5.14. Similarly, Arcturus Therapeutics Holdings Inc recorded 502,253 in trading volume during the last 100 days, posting a change of +40.25%.
How ARCT’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for ARCT stands at 0.12. Similarly, the long-term debt-to-equity ratio is also 0.10.
ARCT Stock Stochastic Average
Arcturus Therapeutics Holdings Inc’s raw stochastic average for the past 50 days is currently at 76.16%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 76.16%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 87.20% and 89.90%, respectively.
ARCT Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. This year’s metric has recorded a Price decrease of -6.77%. However, over the past six months, we’ve seen a stronger performance of -0.78%. The price of ARCT fallen by 32.67% over the last 30 days. And in the last five days, it has surged by 57.24%.
